Skip to main content
. 2022 Jan 27;12:814074. doi: 10.3389/fendo.2021.814074

Figure 3.

Figure 3

Urinary glucose excretion changes before and after sodium–glucose cotransporter 2 inhibitor treatment in patients with different levels of renal function.